Status:
RECRUITING
Essential Pro PMCF Study ( rEPIC04E )
Lead Sponsor:
Fundación EPIC
Conditions:
Coronary Artery Disease (CAD)
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Essential Pro to meet EU Medical Device regulation (...
Detailed Description
The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the Essential Pro in a NON-...
Eligibility Criteria
Inclusion
- Patient treated with Essential Pro according to routine hospital practice and following instructions for use
- Informed consent signed
Exclusion
- • Not meet inclusion criteria
Key Trial Info
Start Date :
September 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT05292092
Start Date
September 26 2022
End Date
August 30 2025
Last Update
June 24 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Punta de Europa
Algeciras, Spain, 11207
2
Hospital Clinic de Barcelona
Barcelona, Spain, 08036
3
Hospital Universitario de Jerez de la Frontera
Jerez de la Frontera, Spain, 11407
4
Hospital Universitario de Leon
León, Spain, 24080